178 related articles for article (PubMed ID: 3037179)
1. Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
Fallo F; Sonino N; Boscaro M; Armanini D; Mantero F; Dörr HG; Knorr D; Kuhnle U
Klin Wochenschr; 1987 May; 65(10):437-44. PubMed ID: 3037179
[TBL] [Abstract][Full Text] [Related]
2. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
3. [The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism].
Watanabe Y; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1995 Mar; 71(2):149-66. PubMed ID: 7750627
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
5. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
6. [Primary hyperaldosteronism].
Opocher G; Rocco S; Carpené G; Armanini D; Mantero F
Minerva Endocrinol; 1995 Mar; 20(1):49-54. PubMed ID: 7651282
[TBL] [Abstract][Full Text] [Related]
7. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
Fallo F; Boscaro M; Sonino N; Mantero F
Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
[TBL] [Abstract][Full Text] [Related]
8. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
O'Mahony S; Burns A; Murnaghan DJ
J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Lee SM; Lightner E; Witte M; Oberfield S; Levine L; New MI
Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis in primary aldosteronism.
Opocher G; Rocco S; Carpenè G; Mantero F
J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):49-55. PubMed ID: 8481351
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
15. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism.
Jiang Y; Zhang C; Wang W; Su T; Zhou W; Jiang L; Zhu W; Xie J; Ning G
J Clin Endocrinol Metab; 2015 May; 100(5):1837-44. PubMed ID: 25695882
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism in childhood due to primary adrenal hyperplasia.
Kikuta Y; Sanjo K; Nakajima K; Ashizawa I; Ojima M
Tohoku J Exp Med; 1988 May; 155(1):57-70. PubMed ID: 3413779
[TBL] [Abstract][Full Text] [Related]
18. A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.
Monno S; Takasu N
Endocrinol Jpn; 1989 Apr; 36(2):315-23. PubMed ID: 2550210
[TBL] [Abstract][Full Text] [Related]
19. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
[TBL] [Abstract][Full Text] [Related]
20. Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent.
Hamlet SM; Gordon RD; Gomez-Sanchez CE; Tunny TJ; Klemm SA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):317-22. PubMed ID: 2856057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
